- ►rsmjournals.com K Abozguia, TT Phan, GN Shivu, A Maher, I … - JRSM, 2007 - jrsm.rsmjournals.com Research is an integral component of any modern health service incorporating
evidence-based practice. To a junior researcher starting a clinical study it may
seem a daunting task, especially given the recent increase in regulation by ... Cited by 1 - Related articles - All 6 versions
R Al-Shahi - JR Soc Med, 2005 - jrsm.rsmjournals.com So it was that in 1997 a standardized system for the review of multicentre
research began with the creation of 13 multicentre research ethics committees
(MRECs). 22 A multicentre research project (taking place over five or more ... Cited by 5 - Related articles - BL Direct - All 7 versions
R Bickerstaffe, P Brock, JM Husson, I Rubin, … - International journal of clinical practice, 2006 - fpm.org.uk Issues Committee of the Faculty of Pharmaceutical Medicine of the ... Royal
Colleges of Physicians of the UK ... R. BICKERSTAFFE, P. BROCK, JM. HUSSON, I.
RUBIN, K. BRAGMAN, K. PATERSON, A. SOMMERVILLE Ethical Issues Committee, ... Cited by 3 - Related articles - View as HTML - BL Direct - All 6 versions
DW Vere - The Textbook of Pharmaceutical Medicine, 2009 - books.google.com 9781405180351_4_014. qxd 8/21/09 9: 32 Page 347 14 Human experimentation-ethics
of first human exposure Duncan W. Vere University of London, UK 14.1
Introduction When faced with the mass of detailed and costly rules for ... Related articles
JJ Anderson, DT Felson, RF Meenan - Arthritis Care & Research - interscience.wiley.com The present investigation was undertaken to explore changes over time in the
design and reporting of trials of second-line drugs in rheumatoid arthritis, in
the characteristics of patients included in the trials, and in the sources ... Cited by 12 - Related articles - All 3 versions
JM Wardlaw, CP Warlow, PAG Sandercock, MS … - The Lancet, 2000 - Elsevier Kennedy Lees and colleagues (June 3, p 1949) 1 present yet another phase III
clinical trial (Glycine Antagonist [gavestinel] in Neuroprotection [GAIN]
International) of a neuroprotective drug (gavestinel, GV150526) that fails ... Cited by 11 - Related articles - BL Direct - All 2 versions
C Counsell - The Lancet, 2001 - Elsevier That recommendation was evidence-based. There are anecdotal reports of bias in
commercially sponsored trials, 2 and in one study, the design and conclusions
(as reported in the discussion section) of commercially sponsored trials ... Cited by 3 - Related articles - BL Direct - All 2 versions
- ►bmj.com J Tully, N Ninis, R Booy, R Viner - British Medical Journal, 2000 - bmj.com The new UK multicentre research ethics committees were set up in autumn 1997
following concerns about the process of ethical review for multicentre studies.
1 2 Both administrative and ethical problems had been encountered when ... Cited by 82 - Related articles - BL Direct - All 7 versions
- ►bmj.com T Smith, EJH Moore, H Tunstall-Pedoe - British Medical Journal, 1997 - bmj.com The Tayside local medical research ethics committee was formed in 1990 as a
joint committee of the Tayside Health Board and the University of Dundee and
consists of 12 members–six medically qualified members, a nurse, a lay ... Cited by 16 - Related articles - BL Direct - All 6 versions
